Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
N Engl J Med ; 390(4): 387, 2024 Jan 25.
Artigo em Inglês | MEDLINE | ID: mdl-38265663
2.
Int J Mol Sci ; 24(3)2023 Jan 27.
Artigo em Inglês | MEDLINE | ID: mdl-36768808

RESUMO

PiZZ (Glu342Lys) α1-antitrypsin deficiency (AATD) is characterized by intrahepatic AAT polymerization and is a risk factor for liver disease development in children. The majority of PiZZ children are disease free, hence this mutation alone is not sufficient to cause the disease. We investigated Z-AAT polymers and the expression of fibrosis-related genes in liver tissues of PiZZ children with different clinical courses. Liver biopsies obtained during 1979-2010 at the Department of Paediatrics, Karolinska University Hospital, Sweden, were subjected to histological re-evaluation, immunohistochemistry and NanoString-based transcriptome profiling using a panel of 760 fibrosis plus 8 bile acid-related genes. Subjects were divided into three groups based on clinical outcomes: NCH (neonatal cholestasis, favourable outcome, n = 5), NCC (neonatal cholestasis, early cirrhosis and liver transplantation, n = 4), and NNCH (no neonatal cholestasis, favourable outcome, n = 5, six biopsies). Hepatocytes containing Z-AAT polymers were abundant in all groups whereas NCC showed higher expression of genes related to liver fibrosis/cirrhosis and lower expression of genes related to lipid, aldehyde/ketone, and bile acid metabolism. Z-AAT accumulation per se cannot explain the clinical outcomes of PiZZ children; however, changes in the expression of specific genes and pathways involved in lipid, fatty acid, and steroid metabolism appear to reflect the degree of liver injury.


Assuntos
Colestase , Deficiência de alfa 1-Antitripsina , Humanos , Criança , Recém-Nascido , Deficiência de alfa 1-Antitripsina/patologia , Fígado/metabolismo , Cirrose Hepática/genética , Cirrose Hepática/patologia , Colestase/metabolismo , Biópsia , Progressão da Doença , Lipídeos
3.
Arch Dermatol Res ; 312(10): 715-724, 2020 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-32166376

RESUMO

Hidradenitis suppurativa (HS) rarely affects pediatric patients. The literature on pediatric HS patients is scarce. This is a cross-sectional study based on case note review or interviews and clinical examination of 140 pediatric patients undergoing secondary or tertiary level care. Patients were predominantly female (75.5%, n = 105) with a median age of 16. 39% reported 1st-degree relative with HS. Median BMI percentile was 88, and 11% were smokers (n = 15). Median modified Sartorius score was 8.5. Notable comorbidities found were acne (32.8%, n = 45), hirsutism (19.3%, n = 27), and pilonidal cysts (16.4%, n = 23). Resorcinol (n = 27) and clindamycin (n = 25) were the most frequently used topical treatments. Patients were treated with tetracycline (n = 32), or oral clindamycin and rifampicin in combination (n = 29). Surgical excision was performed in 18 patients, deroofing in five and incision in seven patients. Obesity seemed to be prominent in the pediatric population and correlated to parent BMI, suggesting a potential for preventive measures for the family. Disease management appeared to be similar to that of adult HS, bearing in mind that the younger the patient, the milder the disease in majority of cases.


Assuntos
Antibacterianos/administração & dosagem , Procedimentos Cirúrgicos Dermatológicos , Hidradenite Supurativa/terapia , Obesidade/epidemiologia , Fumar/epidemiologia , Acne Vulgar/epidemiologia , Administração Cutânea , Administração Oral , Adolescente , Índice de Massa Corporal , Criança , Clindamicina/administração & dosagem , Comorbidade , Estudos Transversais , Quimioterapia Combinada/métodos , Feminino , Hidradenite Supurativa/epidemiologia , Hirsutismo/epidemiologia , Humanos , Masculino , Seio Pilonidal/epidemiologia , Resorcinóis/administração & dosagem , Rifampina/administração & dosagem , Fatores de Risco , Índice de Gravidade de Doença , Tetraciclina/administração & dosagem , Resultado do Tratamento , Adulto Jovem
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...